REFLAB ApS: Financial statements 2018
CVR: 15322586
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
REFLAB ApS (CVR 15322586) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,308,574 and a net result of DKK -426,275 compared with DKK -1,008,355 the year before. That is an increase of 18.9% compared with the year before. Equity in the 2018 report amounted to DKK 242,481. The solvency ratio was 5.9%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 3,308,574
- Profit/Loss
- DKK -426,275
- Equity
- DKK 242,481
- Total Assets
- DKK 4,127,481
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 3.3 mio. | -426 t. | 242 t. | 8 |
| 2017 | - | 2.8 mio. | -1 mio. | 669 t. | 7 |
| 2016 | - | 1.7 mio. | -1.8 mio. | 1.7 mio. | 6 |
| 2015 | - | 3 mio. | -382 t. | 3.5 mio. | - |
| 2014 | - | 4.6 mio. | 1.1 mio. | 3.9 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
REFLAB ApS has published its annual report for 2017. Gross profit came to DKK 2,782,613, and the net result was DKK -1,008,355.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen and Katrine Baumann Markussen. The company is owned by R-Biopharm AG. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity in the 2025 report amounted to DKK -635,048.